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Dear Editor,
We read with great interest the article by Bueno Filho et al.
entitled ‘‘Rare association of cutaneous vasculitis, IgA
nephropathy and antiphospholipid antibody syndrome with
tuberculous lymphadenitis’’ that was published in the
esteemed journal Clinics. The authors presented an interest-
ing case of cutaneous vasculitis, IgA nephropathy and
antiphospholipid antibody syndrome with tuberculous lym-
phadenitis in a 45-year-old woman (1). I would like to
mention a few points regarding this paper. A definitive
pathologic IgA nephropathy diagnosis based on immunos-
taining assays requires the presence of dominant mesangial
IgA depositions in the absence of significant C1q depositions
to rule out lupus nephritis (2–5), which the authors should
note. Moreover, the detection of significant fibrin deposition
along with IgA deposits can help differentiate between
primary IgA nephropathy and Henoch-Scho¨nlein purpura
nephropathy (2–5). Therefore, the authors should also discuss
this point. Bueno Filho et al. classified themorphologic lesions
of IgA nephropathy in renal biopsies as ‘‘focal and segmental
sclerosis with mild focal and chronic tubulointerstitial
damage’’. Indeed, as a result of the publication of the
Oxford classification of IgA nephropathy in 2009 (2,5), it is
necessary to describe the morphologic lesions of IgA
nephropathy according to this classification system (6–8).
Furthermore, figure 2C shows a normal glomerulus, which is
in contrast to the describedmorphologic features. The authors
reported the final diagnosis as a combination of tuberculous
lymphadenitis, cutaneous leukocytoclastic vasculitis, primary
IgA nephropathy and anti-phospholipid antibody syndrome.
However, the presence of morphologic lesions upon renal
biopsy suggests anti-phospholipid syndrome nephropathy
and should have been reported (9–11).
Anti-phospholipid antibody syndrome is a vaso-occlusive
disease (12,13) that affects renal tissue and has various
morphologic lesions, some of which are characteristic of the
disease (14). Accurate documentation and reporting of such
rare cases are necessary to determine the complete spectrum
of this disorder and improve the understanding of its
pathophysiology. Bueno Filho et al. merit compliments for
bringing this interesting case to this journal for discussion.
Such discussions may help increase awareness of anti-
phospholipid antibody syndrome among pathologists and
nephrologists, particularly in developing countries.
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